pharmaceutical products

Draft Resolution number 760, December 27th, 2019. Number of pages: 38; Language(s): Portuguese

This Draft Resolution establishes the minimal technical requirements for relative bioavailability and bioequivalence studies that supports dossier of consent for clinical research, market authorization or post-market authorization of medicines, in the terms of this resolution.